Literature DB >> 29280923

Local Anesthetic Systemic Toxicity in Total Joint Arthroplasty: Incidence and Risk Factors in the United States From the National Inpatient Sample 1998-2013.

Daniel S Rubin, Monica M Matsumoto, Guy Weinberg, Steven Roth.   

Abstract

BACKGROUND: Local anesthetic systemic toxicity (LAST) is a rare and potentially devastating complication of regional anesthesia. Single-institution registries have reported a decreasing incidence, but these results have limited broad applicability. A recent study using a US database found a relatively high incidence of LAST. We used the National Inpatient Sample, a US database of inpatient admissions, to identify the national incidence and associated risk factors for LAST in total joint arthroplasties.
METHODS: In this retrospective study, we studied patients undergoing hip, knee, or shoulder arthroplasty, from 1998 to 2013, with an adjunct peripheral nerve blockade. We used a multivariable logistic regression to identify patient conditions, hospital level variables, and procedure sites associated with LAST.
RESULTS: A total of 710,327 discharges met inclusion criteria. The average adjusted incidence was 1.04 per 1000 peripheral nerve blocks, with decreasing trend over the 15-year study period (odds ratio [OR], 0.90; P = 0.002). Shoulder arthroplasty (OR, 4.35; P = 0.0001) compared with knee or hip arthroplasty and medium-size (OR, 3.34; P = 0.003) and large-size (OR, 2.40; P = 0.025) hospitals as compared with small hospitals were associated with increased odds of LAST.
CONCLUSIONS: The incidence of LAST nationally in total joint arthroplasty with adjunct nerve blocks is similar to recent estimates from academic centers, with a small decreasing trend through the study period. Despite an overall low incidence rate, practitioners should continue to maintain vigilance for manifestations of LAST, especially as the use of regional anesthesia continues to increase.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29280923      PMCID: PMC5777869          DOI: 10.1097/AAP.0000000000000684

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  17 in total

1.  American Society of Regional Anesthesia and Pain Medicine checklist for managing local anesthetic systemic toxicity: 2012 version.

Authors:  Joseph M Neal; Michael F Mulroy; Guy L Weinberg
Journal:  Reg Anesth Pain Med       Date:  2012 Jan-Feb       Impact factor: 6.288

Review 2.  Clinical presentation of local anesthetic systemic toxicity: a review of published cases, 1979 to 2009.

Authors:  Guido Di Gregorio; Joseph M Neal; Richard W Rosenquist; Guy L Weinberg
Journal:  Reg Anesth Pain Med       Date:  2010 Mar-Apr       Impact factor: 6.288

3.  Cardiac Arrest and Seizures Caused by Local Anesthetic Systemic Toxicity After Peripheral Nerve Blocks: Should We Still Fear the Reaper?

Authors:  Spencer S Liu; Sarah Ortolan; Miguel Vizarreta Sandoval; Jodie Curren; Kara G Fields; Stavros G Memtsoudis; Jacques T YaDeau
Journal:  Reg Anesth Pain Med       Date:  2016 Jan-Feb       Impact factor: 6.288

4.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  BMJ       Date:  2007-10-20

5.  Major complications of regional anesthesia in France: The SOS Regional Anesthesia Hotline Service.

Authors:  Yves Auroy; Dan Benhamou; Laurent Bargues; Claude Ecoffey; Bruno Falissard; Frédéric J Mercier; Hervé Bouaziz; Kamran Samii; Frédéric Mercier
Journal:  Anesthesiology       Date:  2002-11       Impact factor: 7.892

6.  Incidence of Local Anesthetic Systemic Toxicity in Orthopedic Patients Receiving Peripheral Nerve Blocks.

Authors:  Eva E Mörwald; Nicole Zubizarreta; Crispiana Cozowicz; Jashvant Poeran; Stavros G Memtsoudis
Journal:  Reg Anesth Pain Med       Date:  2017 Jul/Aug       Impact factor: 6.288

7.  Anesthesia complications as a childbirth patient safety indicator.

Authors:  Samia El Haj Ibrahim; Moshe Fridman; Lisa M Korst; Kimberly D Gregory
Journal:  Anesth Analg       Date:  2014-10       Impact factor: 5.108

8.  Systemic absorption of mepivacaine in commonly used regional block procedures.

Authors:  G T Tucker; D C Moore; P O Bridenbaugh; L D Bridenbaugh; G E Thompson
Journal:  Anesthesiology       Date:  1972-09       Impact factor: 7.892

9.  Accuracy of malignant hyperthermia diagnoses in hospital discharge records.

Authors:  Teeda Pinyavat; Henry Rosenberg; Barbara H Lang; Cynthia A Wong; Sheila Riazi; Joanne E Brady; Lena S Sun; Guohua Li
Journal:  Anesthesiology       Date:  2015-01       Impact factor: 7.892

10.  Adverse outcomes associated with nerve stimulator-guided and ultrasound-guided peripheral nerve blocks by supervised trainees: update of a single-site database.

Authors:  Steven L Orebaugh; Michael L Kentor; Brian A Williams
Journal:  Reg Anesth Pain Med       Date:  2012 Nov-Dec       Impact factor: 6.288

View more
  4 in total

1.  Superior hypogastric nerve block (SHNB) for pain control after uterine fibroid embolization (UFE): technique and troubleshooting.

Authors:  Keith Pereira; Louis Maurice Morel-Ovalle; Mehdi Taghipour; Afsheen Sherwani; Roshni Parikh; Jerome Kao; Kirubahara Vaheesan
Journal:  CVIR Endovasc       Date:  2020-09-27

Review 2.  Local anesthetic systemic toxicity: current perspectives.

Authors:  Kariem El-Boghdadly; Amit Pawa; Ki Jinn Chin
Journal:  Local Reg Anesth       Date:  2018-08-08

Review 3.  LOCAL ANESTHETICS AND STEROIDS: CONTRAINDICATIONS AND COMPLICATIONS - CLINICAL UPDATE.

Authors:  Tatjana Šimurina; Boris Mraović; Miroslav Župčić; Sandra Graf Župčić; Marina Vulin
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

Review 4.  Comparison of in vitro and in vivo Toxicity of Bupivacaine in Musculoskeletal Applications.

Authors:  Jasper G Steverink; Susanna Piluso; Jos Malda; Jorrit-Jan Verlaan
Journal:  Front Pain Res (Lausanne)       Date:  2021-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.